Cargando…

Comparative effects of oleoyl-estrone and a specific β(3)-adrenergic agonist (CL316, 243) on the expression of genes involved in energy metabolism of rat white adipose tissue

BACKGROUND: The combination of oleoyl-estrone (OE) and a selective β(3)-adrenergic agonist (B3A; CL316,243) treatment in rats results in a profound and rapid wasting of body reserves (lipid). METHODS: In the present study we investigated the effect of OE (oral gavage) and/or B3A (subcutaneous consta...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrer-Lorente, Raquel, Cabot, Cristina, Fernández-López, José-Antonio, Alemany, Marià
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841192/
https://www.ncbi.nlm.nih.gov/pubmed/20184727
http://dx.doi.org/10.1186/1743-7075-7-15
_version_ 1782179089849778176
author Ferrer-Lorente, Raquel
Cabot, Cristina
Fernández-López, José-Antonio
Alemany, Marià
author_facet Ferrer-Lorente, Raquel
Cabot, Cristina
Fernández-López, José-Antonio
Alemany, Marià
author_sort Ferrer-Lorente, Raquel
collection PubMed
description BACKGROUND: The combination of oleoyl-estrone (OE) and a selective β(3)-adrenergic agonist (B3A; CL316,243) treatment in rats results in a profound and rapid wasting of body reserves (lipid). METHODS: In the present study we investigated the effect of OE (oral gavage) and/or B3A (subcutaneous constant infusion) administration for 10 days to overweight male rats, compared with controls, on three distinct white adipose tissue (WAT) sites: subcutaneous inguinal, retroperitoneal and epididymal. Tissue weight, DNA (and, from these values cellularity), cAMP content and the expression of several key energy handling metabolism and control genes were analyzed and computed in relation to the whole site mass. RESULTS: Both OE and B3A significantly decreased WAT mass, with no loss of DNA (cell numbers). OE decreased and B3A increased cAMP. Gene expression patterns were markedly different for OE and B3A. OE tended to decrease expression of most genes studied, with no changes (versus controls) of lipolytic but decrease of lipogenic enzyme genes. The effects of B3A were widely different, with a generalized increase in the expression of most genes, including the adrenergic receptors, and, especially the uncoupling protein UCP1. DISCUSSION: OE and B3A, elicit widely different responses in WAT gene expression, end producing similar effects, such as shrinking of WAT, loss of fat, maintenance of cell numbers. OE acted essentially on the balance of lipolysis-lipogenesis and the blocking of the uptake of substrates; its decrease of synthesis favouring lipolysis. B3A induced a shotgun increase in the expression of most regulatory systems in the adipocyte, an effect that in the end favoured again the loss of lipid; this barely selective increase probably produces inefficiency, which coupled with the increase in UCP1 expression may help WAT to waste energy through thermogenesis. CONCLUSIONS: There were considerable differences in the responses of the three WAT sites. OE in general lowered gene expression and stealthily induced a substrate imbalance. B3A increasing the expression of most genes enhanced energy waste through inefficiency rather than through specific pathway activation. There was not a synergistic effect between OE and B3A in WAT, but their combined action increased WAT energy waste.
format Text
id pubmed-2841192
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28411922010-03-18 Comparative effects of oleoyl-estrone and a specific β(3)-adrenergic agonist (CL316, 243) on the expression of genes involved in energy metabolism of rat white adipose tissue Ferrer-Lorente, Raquel Cabot, Cristina Fernández-López, José-Antonio Alemany, Marià Nutr Metab (Lond) Research BACKGROUND: The combination of oleoyl-estrone (OE) and a selective β(3)-adrenergic agonist (B3A; CL316,243) treatment in rats results in a profound and rapid wasting of body reserves (lipid). METHODS: In the present study we investigated the effect of OE (oral gavage) and/or B3A (subcutaneous constant infusion) administration for 10 days to overweight male rats, compared with controls, on three distinct white adipose tissue (WAT) sites: subcutaneous inguinal, retroperitoneal and epididymal. Tissue weight, DNA (and, from these values cellularity), cAMP content and the expression of several key energy handling metabolism and control genes were analyzed and computed in relation to the whole site mass. RESULTS: Both OE and B3A significantly decreased WAT mass, with no loss of DNA (cell numbers). OE decreased and B3A increased cAMP. Gene expression patterns were markedly different for OE and B3A. OE tended to decrease expression of most genes studied, with no changes (versus controls) of lipolytic but decrease of lipogenic enzyme genes. The effects of B3A were widely different, with a generalized increase in the expression of most genes, including the adrenergic receptors, and, especially the uncoupling protein UCP1. DISCUSSION: OE and B3A, elicit widely different responses in WAT gene expression, end producing similar effects, such as shrinking of WAT, loss of fat, maintenance of cell numbers. OE acted essentially on the balance of lipolysis-lipogenesis and the blocking of the uptake of substrates; its decrease of synthesis favouring lipolysis. B3A induced a shotgun increase in the expression of most regulatory systems in the adipocyte, an effect that in the end favoured again the loss of lipid; this barely selective increase probably produces inefficiency, which coupled with the increase in UCP1 expression may help WAT to waste energy through thermogenesis. CONCLUSIONS: There were considerable differences in the responses of the three WAT sites. OE in general lowered gene expression and stealthily induced a substrate imbalance. B3A increasing the expression of most genes enhanced energy waste through inefficiency rather than through specific pathway activation. There was not a synergistic effect between OE and B3A in WAT, but their combined action increased WAT energy waste. BioMed Central 2010-02-25 /pmc/articles/PMC2841192/ /pubmed/20184727 http://dx.doi.org/10.1186/1743-7075-7-15 Text en Copyright ©2010 Ferrer-Lorente et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Ferrer-Lorente, Raquel
Cabot, Cristina
Fernández-López, José-Antonio
Alemany, Marià
Comparative effects of oleoyl-estrone and a specific β(3)-adrenergic agonist (CL316, 243) on the expression of genes involved in energy metabolism of rat white adipose tissue
title Comparative effects of oleoyl-estrone and a specific β(3)-adrenergic agonist (CL316, 243) on the expression of genes involved in energy metabolism of rat white adipose tissue
title_full Comparative effects of oleoyl-estrone and a specific β(3)-adrenergic agonist (CL316, 243) on the expression of genes involved in energy metabolism of rat white adipose tissue
title_fullStr Comparative effects of oleoyl-estrone and a specific β(3)-adrenergic agonist (CL316, 243) on the expression of genes involved in energy metabolism of rat white adipose tissue
title_full_unstemmed Comparative effects of oleoyl-estrone and a specific β(3)-adrenergic agonist (CL316, 243) on the expression of genes involved in energy metabolism of rat white adipose tissue
title_short Comparative effects of oleoyl-estrone and a specific β(3)-adrenergic agonist (CL316, 243) on the expression of genes involved in energy metabolism of rat white adipose tissue
title_sort comparative effects of oleoyl-estrone and a specific β(3)-adrenergic agonist (cl316, 243) on the expression of genes involved in energy metabolism of rat white adipose tissue
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841192/
https://www.ncbi.nlm.nih.gov/pubmed/20184727
http://dx.doi.org/10.1186/1743-7075-7-15
work_keys_str_mv AT ferrerlorenteraquel comparativeeffectsofoleoylestroneandaspecificb3adrenergicagonistcl316243ontheexpressionofgenesinvolvedinenergymetabolismofratwhiteadiposetissue
AT cabotcristina comparativeeffectsofoleoylestroneandaspecificb3adrenergicagonistcl316243ontheexpressionofgenesinvolvedinenergymetabolismofratwhiteadiposetissue
AT fernandezlopezjoseantonio comparativeeffectsofoleoylestroneandaspecificb3adrenergicagonistcl316243ontheexpressionofgenesinvolvedinenergymetabolismofratwhiteadiposetissue
AT alemanymaria comparativeeffectsofoleoylestroneandaspecificb3adrenergicagonistcl316243ontheexpressionofgenesinvolvedinenergymetabolismofratwhiteadiposetissue